Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online [Internet]. 2007;15(2):149–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489
Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet]. 2011;96(5):1066–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050
Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet]. 2017;108(4):572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551
Shaulov T, Vélez MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod Genet [Internet]. 2015;32(7):1043–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26041679
Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin- releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod [Internet]. 1999;14(3):683–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10221695
Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013;(8):CD010550.
Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018;36(1):94–101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29111312
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril [Internet]. 2013;99(3):663–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23391409
Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online [Internet]. 2010;21(4):566–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957
Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet]. 2014;41(2):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627
Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil Steril [Internet]. 2010;94(2):496–501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589517
Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(3 Pt 2):S52--6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921
Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009;19(3):343–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479
Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000;15(1):165–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207
Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG- primed in vitro maturation cycles. Hum Reprod [Internet]. 2008;23(12):2680–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885
Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009;92(3):907–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750
Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007;110(4):885–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024
Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601–8.
Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May;99(6):1476–84.
Coyne K, Purdy M, Oâ€TMLeary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front Public Heal [Internet]. 2014;2. Available from: http://journal.frontiersin.org/article/10.3389/fpubh.2014.00246/abstract
Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet [Internet]. 2014;31(7):927–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484
Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet]. 2012;97(5):1039–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086